{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:55:18Z","timestamp":1767891318172,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304297"],"award-info":[{"award-number":["82304297"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.bioorg.2024.107340","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T22:19:17Z","timestamp":1712355557000},"page":"107340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Structure-guided design of novel biphenyl-quinazoline derivatives as potent non-nucleoside reverse transcriptase inhibitors featuring improved anti-resistance, selectivity, and solubility"],"prefix":"10.1016","volume":"147","author":[{"given":"Jin-Si","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke-Xin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Pannecouque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik","family":"De Clercq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen-Er","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bioorg.2024.107340_b0005","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1021\/acs.jmedchem.2c01875","article-title":"Structure-Based Optimization of 2,4,5-Trisubstituted Pyrimidines as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Exploiting the Tolerant Regions of the Non-Nucleoside Reverse Transcriptase Inhibitors\u2019 Binding Pocket","volume":"66","author":"Zhao","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.bioorg.2024.107340_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115586","article-title":"Fluorine in Anti-HIV Drugs Approved by FDA from 1981 to 2023","volume":"258","author":"Han","year":"2023","journal-title":"Eur J Med Chem"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107340_b0015","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1016\/j.apsb.2023.01.003","article-title":"Discovery of Novel Sulfonamide Substituted Indolylarylsulfones as Potent HIV-1 Inhibitors with Better Safety Profiles","volume":"13","author":"Gao","year":"2023","journal-title":"Acta Pharm Sin B"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107340_b0020","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3390\/v14051027","article-title":"Insights into HIV-1 Reverse Transcriptase (RT) Inhibition and Drug Resistance from Thirty Years of Structural Studies","volume":"14","author":"Singh","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.bioorg.2024.107340_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115196","article-title":"Recent Advances on Dual Inhibitors Targeting HIV Reverse Transcriptase Associated Polymerase and Ribonuclease H","volume":"250","author":"Kang","year":"2023","journal-title":"Eur J Med Chem"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107340_b0030","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/med.21760","article-title":"Druggability Modification Strategies of the Diarylpyrimidine-Type Non-Nucleoside Reverse Transcriptase Inhibitors","volume":"41","author":"Ding","year":"2021","journal-title":"Med Res Rev"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107340_b0035","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.apsb.2019.11.010","article-title":"Development of Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs): Our Past Twenty Years","volume":"10","author":"Zhuang","year":"2020","journal-title":"Acta Pharm Sin B"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107340_b0040","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/cmdc.201800577","article-title":"Recent Advances in the Design and Development of Non-Nucleoside Reverse Transcriptase Inhibitor Scaffolds","volume":"14","author":"Shirvani","year":"2019","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2024.107340_b0045","doi-asserted-by":"crossref","first-page":"1294966","DOI":"10.3389\/fphar.2023.1294966","article-title":"Current Drugs for HIV-1: from Challenges to Potential in HIV\/AIDS","volume":"14","author":"Peng","year":"2023","journal-title":"Fron Pharmacol"},{"key":"10.1016\/j.bioorg.2024.107340_b0050","doi-asserted-by":"crossref","first-page":"1277059","DOI":"10.3389\/fmed.2023.1277059","article-title":"Impacts of Ainuovirine-Based and Efavirenz-Based Antiretroviral Therapies on the Lipid Profile of HIV\/AIDS Patients in Southern China: a Real-World Study","volume":"10","author":"Zhang","year":"2024","journal-title":"Fron Med"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107340_b0055","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2174\/1570162X18666200620211922","article-title":"The New NNRTI ACC007 Combined with Lamivudine and Tenofovir Disoproxil Fumarate Show Synergy Anti-HIV Activity In Vitro","volume":"18","author":"Huang","year":"2020","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.bioorg.2024.107340_b0060","article-title":"Disubstituted Pyrimidine-5-Carboxamide Derivatives as Novel HIV-1 NNRTIs: Crystallographic Overlay-Based Molecular Design","volume":"246","author":"Feng","year":"2023","journal-title":"Synthesis, and Biological Evaluation, Eur J Med Chem"},{"key":"10.1016\/j.bioorg.2024.107340_b0065","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ijbiomac.2021.01.076","article-title":"Trends and Strategies to Combat Viral Infections: A Review on FDA Approved Antiviral Drugs","volume":"172","author":"Tompa","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.bioorg.2024.107340_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106413","article-title":"Structure-Directed Linker Optimization of Novel HEPTs as Non-Nucleoside Inhibitors of HIV-1 Reverse Transcriptase","volume":"133","author":"Hao","year":"2023","journal-title":"Bioorg Chem"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107340_b0075","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.apsb.2022.08.017","article-title":"Development of Fluorine-substituted NH2-Biphenyl-Diarylpyrimidines as Highly Potent Non-nucleoside Reverse Transcriptase Inhibitors: Boosting the Safety and Metabolic Stability","volume":"13","author":"Jin","year":"2023","journal-title":"Acta Pharm Sin B"},{"issue":"12","key":"10.1016\/j.bioorg.2024.107340_b0080","doi-asserted-by":"crossref","first-page":"8478","DOI":"10.1021\/acs.jmedchem.2c00468","article-title":"Structure-Based Discovery of Novel NH2-Biphenyl-Diarylpyrimidines as Potent Non-Nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Safety: From NH2-Naphthyl-Diarylpyrimidine to NH2-Biphenyl-Diarylpyrimidine","volume":"65","author":"Jin","year":"2022","journal-title":"J Med Chem"},{"issue":"9","key":"10.1016\/j.bioorg.2024.107340_b0085","doi-asserted-by":"crossref","first-page":"6193","DOI":"10.1021\/acs.jmedchem.2c02055","article-title":"N-Phenyl-1-(phenylsulfonyl)-1H-1,2,4-triazol-3-amine as a New Class of HIV-1 Non-nucleoside Reverse Transcriptase Inhibitor","volume":"66","author":"Lane","year":"2023","journal-title":"J Med Chem"},{"issue":"7","key":"10.1016\/j.bioorg.2024.107340_b0090","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1016\/j.apsb.2023.03.022","article-title":"Picomolar Inhibitor of Reverse Transcriptase Featuring Significantly Improved Metabolic Stability","volume":"13","author":"Sang","year":"2023","journal-title":"Acta Pharm Sin B"},{"issue":"12","key":"10.1016\/j.bioorg.2024.107340_b0095","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1016\/j.apsb.2023.07.008","article-title":"Structure-Based Design of Novel Heterocycle-Substituted ATDP Analogs as Non-Nucleoside Reverse Transcriptase Inhibitors with Improved Selectivity and Solubility","volume":"13","author":"Zhao","year":"2023","journal-title":"Acta Pharm Sin B"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107340_b0100","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.apsb.2019.09.007","article-title":"Improving the Positional Adaptability: Structure-Based Design of Biphenyl-Substituted Diaryltriazines as Novel Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors","volume":"10","author":"Jin","year":"2020","journal-title":"Acta Pharm Sin B"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107340_b0105","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.cclet.2019.11.020","article-title":"Fragment-Based Discovery of Sulfur-containing Diarylbenzopyrimidines as Novel Nonnucleoside Reverse Transcriptase Inhibitors","volume":"31","author":"Han","year":"2020","journal-title":"Chin Chem Lett"},{"issue":"5","key":"10.1016\/j.bioorg.2024.107340_b0110","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1021\/acsinfecdis.9b00229","article-title":"Molecular Hybridization-Inspired Optimization of Diarylbenzopyrimidines as HIV-1 Nonnucleoside Reverse Transcriptase Inhibitors with Improved Activity Against K103N and E138K Mutants and Pharmacokinetic Profiles","volume":"6","author":"Han","year":"2020","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bioorg.2024.107340_b0115","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.ejmech.2018.01.016","article-title":"Discovery of Biphenyl-Substituted Diarylpyrimidines as Non-Nucleoside Reverse Transcriptase Inhibitors with High Potency Against Wild-Type and Mutant HIV-1","volume":"145","author":"Jin","year":"2018","journal-title":"Eur J Med Chem"},{"issue":"24","key":"10.1016\/j.bioorg.2024.107340_b0120","first-page":"11430","article-title":"Ligand-Based Design of Nondimethylphenyl-Diarylpyrimidines with Improved Metabolic Stability","volume":"62","author":"Sang","year":"2019","journal-title":"Safety, and Oral Pharmacokinetic Profiles, J Med Chem"},{"issue":"17","key":"10.1016\/j.bioorg.2024.107340_b0125","doi-asserted-by":"crossref","first-page":"7991","DOI":"10.1021\/acs.jmedchem.6b00738","article-title":"Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance Profiles","volume":"59","author":"Kang","year":"2016","journal-title":"J Med Chem"},{"issue":"9","key":"10.1016\/j.bioorg.2024.107340_b0130","doi-asserted-by":"crossref","first-page":"4837","DOI":"10.1021\/acs.jmedchem.0c00117","article-title":"Structure-Based Bioisosterism Yields HIV-1 NNRTIs with Improved Drug-Resistance Profiles and Favorable Pharmacokinetic Properties","volume":"63","author":"Kang","year":"2020","journal-title":"J Med Chem"},{"issue":"10","key":"10.1016\/j.bioorg.2024.107340_b0135","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1021\/acs.jmedchem.7b00332","article-title":"Structure-Based Optimization of Thiophene[3,2-d]pyrimidine Derivatives as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Improved Potency against Resistance-Associated Variants","volume":"60","author":"Kang","year":"2017","journal-title":"J Med Chem"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107340_b0140","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1021\/acs.jmedchem.8b01656","article-title":"Identification of Dihydrofuro[3,4- d]pyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Promising Antiviral Activities and Desirable Physicochemical Properties","volume":"62","author":"Kang","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bioorg.2024.107340_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118498","article-title":"Is Prodrug Design an Approach to Increase Water Solubility?","volume":"568","author":"Sanches","year":"2019","journal-title":"Int J Pharm"},{"issue":"7","key":"10.1016\/j.bioorg.2024.107340_b0150","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/17460441.2020.1750591","article-title":"Nanonization Techniques to Overcome Poor Water-Solubility with Drugs","volume":"15","author":"Da Silva","year":"2020","journal-title":"Expert Opin Drug Discov"},{"issue":"7\u20138","key":"10.1016\/j.bioorg.2024.107340_b0155","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.drudis.2010.02.009","article-title":"Nanonization Strategies for Poorly Water-Soluble Drugs","volume":"16","author":"Chen","year":"2011","journal-title":"Drug Discov Today"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107340_b0160","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1021\/acs.jmedchem.1c01676","article-title":"Discovery of Novel Pyridine-Dimethyl-Phenyl-DAPY Hybrids by Molecular Fusing of Methyl-Pyrimidine-DAPYs and Difluoro-Pyridinyl-DAPYs: Improving the Druggability toward High Inhibitory Activity","volume":"65","author":"Ding","year":"2022","journal-title":"Solubility, Safety, and PK, J Med Chem"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824002451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824002451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T08:57:03Z","timestamp":1715677023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824002451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":32,"alternative-id":["S0045206824002451"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107340","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-guided design of novel biphenyl-quinazoline derivatives as potent non-nucleoside reverse transcriptase inhibitors featuring improved anti-resistance, selectivity, and solubility","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107340","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107340"}}